Pilar de la Rocha Mur/LinkedIn
Jul 11, 2026, 18:53
Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
Pilar de la Rocha Mur, Vice-President, Head of EMEA at BeOne Medicines, shared on LinkedIn:
”Trust is still the real currency in clinical research.
That was the theme that ran through the BeOne Medicines investigator meeting at EHA 2026 in Stockholm, and it’s one I keep coming back to.
Last night in Stockholm, I had the privilege of being in a room with some of Europe‘s leading hematology investigators.
Around 100 experts with one shared purpose: making clinical research better for patients.
What stayed with me the most was the quality of the conversation.
Here are my two takeaways from an evening that reminded me why this work matters.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 9, 2026, 11:22Saqib Ullah: Why Do Red Blood Cells Autoagglutinate
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation
-
Aug 9, 2026, 10:01Irma Bagdoniene: Plaque Stability and the Importance of LDL Lowering
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine